Home  >  Products  >  PRDM12 (PR domain containing 12) Blocking Peptide (the N terminal of protein) (100ug)
PRDM12 (PR domain containing 12) Blocking Peptide (the N terminal of protein) (100ug)

PRDM12 (PR domain containing 12) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PRDM12 antibody (Catalogue #: ARP33218_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP33218
Size: 100 ug
Weight: 40kDa
Gene: 59335
Format: Lyophilized powder
Target: PRDM12 belongs to PR-domain family which are involved in human cancers in an unusual yin-yang fashion. Two products are normally produced from a PR-domain family member which differ by the presence or absence of the PR domain; the PR-plus product is disrupted or underexpressed whereas the PR-minus product is present or overexpressed in cancer cells. This imbalance in the amount of the two products, a result of either genetic or epigenetic events, appears to be an important cause of malignancy. PRDM12 may have a potential role in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion.
Alternative names: PFM9
See Full Product Listings >